Jardiance (empagliflozin): Diabetes Drug Side Effects & Dosage
Jardiance (empagliflozin) is a drug that belongs to the drug class SGLT2 inhibitors. It is prescribed to manage blood sugar levels in people with type 2 diabetes. Common side effects include UTIs, upper respiratory tract infections, elevated cholesterol levels, and joint pain. Pregnancy and breastfeeding safety information is provided.
DA: 66 PA: 62 MOZ Rank: 91